Navigation Links
PharmAthene Reports First Quarter 2008 Financial Results
Date:5/13/2008

irst quarter 2008 financial results on Tuesday, May 13, 2008 beginning at 4:30 p.m. E.T. The dial-in number within the United States is 866-770-7129. The dial-in number for international callers is 617-213-8067. The participant passcode is 26177716.

Conference Call Replay

A replay of the conference call will be available for 30 days, beginning at approximately 6:30 p.m. E.T. May 13, 2008 until approximately 11:50 p.m. E.T. June 13, 2008. The dial-in number from within the United States is 888-286-8010. For international callers, the dial-in number is 617-801-6888. The participant passcode is 15975144.

Webcast

The conference call will also be webcast and can be accessed from the company's website at http://www.pharmathene.com. A link to the webcast may be found on both the Home Page and also under the Investor Relations section of the website. The webcast will be available for 30 days, or until June 13, 2008.

About PharmAthene, Inc.

PharmAthene's (Amex: PIP) mission is to be the premier company worldwide specializing in the development and commercialization of therapeutic and prophylactic products for defense against biological and chemical threats. Since its inception, PharmAthene has pursued an acquisitive growth strategy focused on high priority, next generation biodefense products that are in a class of products the government has expressed a clear need and intent to procure. PharmAthene's portfolio currently includes five biodefense medical countermeasures: Recombinant Protective Antigen (rPA) anthrax vaccine; Valortim(TM), an anthrax anti-toxin therapeutic which is being co-developed with Medarex; Protexia(R) a novel recombinant bioscavenger to p
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008
2. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
3. PharmAthene Reports Year-End 2007 Financial Results
4. Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthenes Protexia(R) Program
5. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
6. PharmAthene to Delay Release of Full Year 2007 Financial Results
7. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
10. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
11. PharmAthene to Present at the BIO CEO & Investor Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... cellular biologists have made tremendous scientific advances by ... and pathways. Researchers at the University of Wisconsin-Madison ... understanding by putting the pieces back together, mathematically. ... biological engineering, developed computer models of a relatively ...
... ST. LOUIS, Feb. 6 Stereotaxis, Inc. (Nasdaq:, ... financial results for the,fourth quarter and full year ended ... market opens. The Company will host a conference call ... Eastern Time to discuss,the Company,s fourth quarter results and ...
... by $14 millionSEATTLE, Feb. 6 Cell Therapeutics, Inc. ... has engaged the services of a strategic advisory consulting ... developing strategic options for a partnership, asset divestment or ... the preclinical drug development arm of CTI, in Bresso, ...
Cached Biology Technology:Mathematical models reveal how organisms transcend the sum of their genes 2Stereotaxis Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call 2CTI Seeks Strategic Alternative for Italian Facility 2CTI Seeks Strategic Alternative for Italian Facility 3
(Date:4/14/2014)... face the decision of whether to get a ... decision can be even more challenging. Now, a ... decisions in families of children with autism and ... parents reported the benefits of dog ownership included ... to learn responsibility. , "Children with autism spectrum ...
(Date:4/14/2014)... plant growth chamber bound for the International Space ... resupply mission may help expand in-orbit food production ... astronauts something they don,t take for granted, fresh ... to study the in-orbit function and performance of ... and its plant "pillows." The investigation will focus ...
(Date:4/14/2014)... sponges sound like creatures from a B-grade horror movie. ... the deep sea. Scientists first discovered that some sponges ... seven carnivorous species have been found in all of ... marine biologist Lonny Lundsten and two Canadian researchers describes ... deep seafloor, from the Pacific Northwest to Baja California. ...
Breaking Biology News(10 mins):Dog ownership benefits families of children with autism, MU researcher finds 2Veggie will expand fresh food production on space station 2Researchers describe 4 new species of 'killer sponges' from the deep sea 2Researchers describe 4 new species of 'killer sponges' from the deep sea 3
... National Science Foundation (NSF), bioengineers from the University of ... to characterize the thousands of control elements critical to ... mix and match these "DNA parts" in synthetic organisms ... a single designer microbe can take years to create ...
... easy as plugging it into your tee shirt or jeans, ... reporting an advance in that direction with an easier way ... e-Textiles that double as a rechargeable battery. Their report ... a monthly journal. "Wearable electronics represent a developing new ...
... applications ranging from medical devices such as MRIs to surveillance ... of 1996, Congress directed the government to sell essentially all ... government for its investment in the helium and its storage. ... from the National Research Council, assesses whether selling off the ...
Cached Biology News:NSF grant to launch world's first open-source genetic parts production facility 2NSF grant to launch world's first open-source genetic parts production facility 3NSF grant to launch world's first open-source genetic parts production facility 4
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
... The 2/3D Waver Shaker combines shaking and ... with a 330 x 330 mm stainless steel ... top incubator and cold room operation. The platform ... degree for a vigorous with action and rotation ...
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
Biology Products: